Wang, Zhenyu
Xie, MengXia
Jia, Zhongyue
Tao, Ziwei
Zhao, Ping
Ying, Muying
Funding for this research was provided by:
National Nature Science Foundation of China (32260158)
National Nature Science Foundation of China (32260158)
National Nature Science Foundation of China (32260158)
National Nature Science Foundation of China (32260158)
National Nature Science Foundation of China (32260158)
National Nature Science Foundation of China (32260158)
The Science and Technology Foundation of Jiangxi Province (20142BAB204013)
The Science and Technology Foundation of Jiangxi Province (20142BAB204013)
The Science and Technology Foundation of Jiangxi Province (20142BAB204013)
The Science and Technology Foundation of Jiangxi Province (20142BAB204013)
The Science and Technology Foundation of Jiangxi Province (20142BAB204013)
The Science and Technology Foundation of Jiangxi Province (20142BAB204013)
Article History
Received: 21 May 2024
Accepted: 9 September 2024
First Online: 13 September 2024
Change Date: 28 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-025-16814-8
Competing interests
: The authors declare no competing interests.
: The study protocol was reviewed and approved by the Ethics Review Committee of the Taizhou Hospital of Zhejiang Province. All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional and national research committees. The research poses no more than minimal risk to patients and includes appropriate safeguards to protect the patients’ rights, safety and privacy. The informed consent requirement has been waived by Ethics Review Committee of the Taizhou Hospital of Zhejiang Province. Ethical approval and informed consent were not required for the use of the reported cell lines in the present study because A549 and SPC-A1 are established cell lines.